Preventive treatments for breast cancer: recent developments J. E. Alés-MartínezA. RuizA. Frau Educational Series – Red Series Open access 02 December 2014 Pages: 257 - 263
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology P. García-AlfonsoJ. García-FoncillasS. Navarro Clinical Guides in Oncology 06 November 2014 Pages: 264 - 273
Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis Y. LiuX. YunX. Li Research Article 12 November 2014 Pages: 274 - 280
Quantification of circulating endothelial cells as a predictor of response to chemotherapy with platinum and pemetrexed in patients with advanced non-squamous non-small cell lung carcinoma Alfredo Sánchez HernándezOscar José JuanFrancisco García-Piñon Research Article 19 September 2014 Pages: 281 - 288
CC genotype of anti-apoptotic gene BCL-2 (−938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer J. JavidR. MirA. Saxena Research Article 26 September 2014 Pages: 289 - 295
A study comparing two consecutive historical periods in breast cancer with a focus on surgical treatment, loco-regional recurrence, distant metastases and mortality A. García-FernándezC. ChabreraN. Gimenez Research Article 01 October 2014 Pages: 296 - 305
Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway Y. TangP. LiuJ. Fan Research Article 26 September 2014 Pages: 306 - 313
Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells J. ZuoC. ZhangX. Jiang Research Article 16 October 2014 Pages: 314 - 321
Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity? M. López-GómezJ. Moreno-RubioJ. Feliu Research Article 10 October 2014 Pages: 322 - 329
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer S. Hernández-PrietoA. RomeraJ. Sanz-Ortega Research Article 10 October 2014 Pages: 330 - 338